UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer

• Yoshiaki Shoji,
• Takamichi Yokoe,
• Yuta Kobayashi,
• Tomohiro Murakami,
• Peter J. Bostick,
• Yosef Shiloh,
• Dave S. B. Hoon,
• Matias A. Bustos

Affiliations

Yoshiaki Shoji

Department of Translational Molecular Medicine Saint John's Cancer Institute Santa Monica California USA

Takamichi Yokoe

Department of Translational Molecular Medicine Saint John's Cancer Institute Santa Monica California USA

Yuta Kobayashi

Department of Translational Molecular Medicine Saint John's Cancer Institute Santa Monica California USA

Tomohiro Murakami

Department of Translational Molecular Medicine Saint John's Cancer Institute Santa Monica California USA

Peter J. Bostick

Mayo Clinic Care Network Baton Rouge General Medical Center Baton Rouge Louisiana USA

Yosef Shiloh

David and Inez Myers Laboratory for Cancer Genetics Tel Aviv University School of Medicine Tel Aviv Israel

Dave S. B. Hoon

Department of Translational Molecular Medicine Saint John's Cancer Institute Santa Monica California USA

Matias A. Bustos

Department of Translational Molecular Medicine Saint John's Cancer Institute Santa Monica California USA